The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2
Harney, A.S., Karagiannis, G.S., Pignatelli, J., Smith, B.D., Kadioglu, E., Wise, S.C., Hood, M.M., Kaufman, M.D., Leary, C.B., Lu, W.P., Al-Ani, G., Chen, X., Entenberg, D., Oktay, M.H., Wang, Y., Chun, L., De Palma, M., Jones, J.G., Flynn, D.L., Condeelis, J.S.(2017) Mol Cancer Ther 16: 2486-2501
- PubMed: 28838996 
- DOI: https://doi.org/10.1158/1535-7163.MCT-17-0241
- Primary Citation of Related Structures:  
6MWE - PubMed Abstract: 
Tumor-infiltrating myeloid cells promote tumor progression by mediating angiogenesis, tumor cell intravasation, and metastasis, which can offset the effects of chemotherapy, radiation, and antiangiogenic therapy. Here, we show that the kinase switch control inhibitor rebastinib inhibits Tie2, a tyrosine kinase receptor expressed on endothelial cells and protumoral Tie2-expressing macrophages in mouse models of metastatic cancer ...